Human Papillomavirus (HPV) Testing

World Market Report

MCP12454

EXECUTIVE ENGAGEMENTS

POOL

8703
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1218
Interactions with Platform & by Email

PARTICIPANTS

261
Unique # Participated

VALIDATIONS

91
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

102

PAGES

173

EDITION

6

PRICE

USD 4950

CODE

MCP12454


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Human Papillomavirus (HPV) Testing Market to Reach $1.3 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Human Papillomavirus (HPV) Testing estimated at US$881.4 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Hospitals & Clinics, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$679.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Diagnostic Centers segment is readjusted to a revised 6.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $260.1 Million, While China is Forecast to Grow at 5.8% CAGR
The Human Papillomavirus (HPV) Testing market in the U.S. is estimated at US$260.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$235.8 Million by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.Research Institutes Segment to Record 5% CAGR
In the global Research Institutes segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$93.4 Million in the year 2020 will reach a projected size of US$131.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

Abbott Laboratories; Agilent Technologies, Inc.; Arbor Vita Corporation; Becton, Dickinson & Company; Cepheid, Inc.; Daan Gene Co., Ltd.; Diagcor Bioscience Incorporation Ltd.; Enzo Biochem, Inc.; F. Hoffmann-La Roche AG; Fujirebio US, Inc.; Greiner Bio-One International GmbH; Hologic, Inc.; Hybribio Limited; Medical & Biological Laboratories Co. Ltd.; Norgen Biotek Corporation; Promega Corporation; Qiagen NV; Seegene, Inc.; Takara Bio, Inc.; Thermo Fisher Scientific, Inc.; Zytovision GmbH

SEGMENTS

» End-Use (Hospitals & Clinics, Diagnostic Centers, Research Institutes)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Human Papillomavirus (HPV) Testing – Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Human Papillomavirus (HPV) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Human Papillomavirus (HPV) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Human Papillomavirus (HPV) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
UNITED STATES
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
JAPAN
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
CHINA
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
EUROPE
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Papillomavirus (HPV) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Papillomavirus (HPV) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
FRANCE
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
GERMANY
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
UNITED KINGDOM
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Human Papillomavirus (HPV) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Human Papillomavirus (HPV) Testing by End-Use - Hospitals & Clinics, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Human Papillomavirus (HPV) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Centers and Research Institutes for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com